Abstract
We report the case of a patient with Kaposi's sarcoma after kidney transplantation. Despite the discontinuation of azathioprine and a reduction in the cyclosporin dosage, the disease continued to evolve, and antineoplastic treatment became necessary. After 14 cycles of vinorelbine chemotherapy, there was a 75% regression of the initial lesions, despite the continuation of cyclosporin A.
| Original language | English |
|---|---|
| Pages (from-to) | 281-283 |
| Number of pages | 3 |
| Journal | Dermatology |
| Volume | 194 |
| Issue number | 3 |
| Publication status | Published - 1997 |
Keywords
- Kaposi's sarcoma
- Kidney transplantation
- Vinorelbine
ASJC Scopus subject areas
- Dermatology
Fingerprint Dive into the research topics of 'Vinorelbine therapy for Kaposi's sarcoma in a kidney transplant patient'. Together they form a unique fingerprint.
Cite this
Brambilla, L., Boneschi, V., Fossati, S., Ferrucci, S., & Finzi, A. F. (1997). Vinorelbine therapy for Kaposi's sarcoma in a kidney transplant patient. Dermatology, 194(3), 281-283.